With newer, longer-acting, and more potent GLP-1RAs increasingly taking over the scene in the treatment of type 2 diabetes and, as of recently, also obesity, it is obvious to speculate whether these compounds would be preferable in the treatment of BAD
All articles and information on this website are for informational and educational purposes only
By improving insulin sensitivity, tirzepatide may help reduce this hormonal imbalance in some people
[1] What is commonly known as a "GLP-1 medication" is a GLP-1 receptor agonist
Night sweats indicate that tirzepatide is triggering a metabolic response, but they are not a direct measure of weight loss effectiveness
Clinical trials have demonstrated tirzepatides superior efficacy in reducing HbA1c and body weight compared to semaglutide, making it an attractive option for patients needing intensified therapy